The increased glucose flux into the polyol pathway via aldose reductase (AR) is recognized as a major contributing factor for the pathogenesis of diabetic neuropathy, whereas little is known about the functional significance of AR in the peripheral nervous system. Spontaneously immortalized Schwann cell lines established from long-term cultures of AR-deficient and normal C57BL/6 mouse dorsal root ganglia and peripheral nerves can be useful tools for studying the physiological and pathological roles of AR. These cell lines, designated as immortalized knockout AR Schwann cells 1 (IKARS1) and 1970C3, respectively, demonstrated distinctive Schwann cell phenotypes, such as spindle-shaped morphology and immunoreactivity to S100, p75 neurotrophin receptor, and vimentin, and extracellular release of neurotrophic factors.
In 'target' organs for diabetic complications, such as peripheral nerves, ocular lenses, retinas, and renal glomeruli, blood glucose is transported into the cells in an insulinindependent manner. Under normoglycemic conditions, most cellular glucose is phosphorylated to glucose 6-phosphate by hexokinase and enters the glycolytic pathway; however, under hyperglycemic conditions, glycolytic pathway saturation and aldose reductase (AR: EC 1.1.1.21) activation escalates glucose flux through the polyol pathway (Gabbay 1975) . In the first, rate-limiting step of this pathway, glucose is metabolized to sorbitol by reduced nicotinamide adenine dinucleotide phosphate-dependent AR. In the second step, sorbitol is converted to fructose by nicotinamide adenine dinucleotide (NAD + )-dependent sorbitol dehydrogenase (SDH: EC 1.1.1.14). Hence, increases in the amount of sorbitol and fructose along with NADPH depletion through AR activation can trigger various metabolic and vascular abnormalities, leading to the development and progression of diabetic complications (Yabe-Nishimura 1998; Tang et al. 2012) . As compared with the considerable number of studies on the pathological roles of AR and the polyol pathway in diabetes, considerably less attention has been paid to the physiological functions of AR, such as osmoregulation in the kidney, fructose production in the male reproductive organs, detoxification of reactive aldehydes, and steroid and catecholamine metabolism (Yabe-Nishimura 1998; Pastel et al. 2012; . Previous studies have reported that AR-deficient mice created by genetic manipulation exhibit no obvious phenotypes except for a partially defective urineconcentrating ability with renal structural abnormalities (Ho et al. 2000; Yang et al. 2006) . Upon inducing diabetes using streptozotocin, these mice show defense against neurological manifestations (Ho et al. 2006 ) and retinal capillary degeneration (Tang et al. 2013) . These findings suggest that increased polyol pathway flux through activated AR is a major contributing factor in the pathogenesis of diabetic complications. A large number of AR inhibitors have been developed and tested in patients with diabetic complications; however, most AR inhibitors show limited efficacy, and only epalrestat is clinically available in Japan (Hotta et al. 2012) .
As glial cells in the peripheral nervous system (PNS), Schwann cells are responsible for trophic support to neurons, saltatory conduction by forming a myelin sheath, and neurite outgrowth during development and regeneration. Because AR is predominantly localized to Schwann cells in the PNS (Kern and Engerman 1982) , the increased glucose flux through the polyol pathway by AR appears to play a major role in defective nerve function, such as reduced nerve conduction velocity, decreased sensation, and impaired axonal regeneration (Eckersley 2002; Misawa et al. 2006) . Moreover, Schwann cells cultured under diabetic conditions have been utilized for the precise polyol pathway investigation (Mizisin et al. 1996; Suzuki et al. 1999) . Spontaneously immortalized Schwann cells immortalized mouse Schwann cells 32 (IMS32) from the long-term cultures of adult ICR mouse peripheral nerves are known to retain distinctive Schwann cell phenotypes (Watabe et al. 1995) , and previous studies by us have revealed significant up-regulation of AR mRNA/protein expression and a marked accumulation of sorbitol and fructose in IMS32 cells under high glucose (30 mM) conditions. Furthermore, the application of AR inhibitors, fidarestat (Sanwa Kagaku Kenkyusho, Nagoya, Japan) and ranirestat (Sumitomo Dainippon Pharma, Osaka, Japan), in high glucose media has been demonstrated to significantly diminish the intracellular polyol content (Sango et al. 2006; HY, NN, ST and KS, unpublished data) . These findings suggest that IMS32 cells under high glucose conditions are a suitable in vitro model for studying polyol pathway-related abnormalities in diabetes (Cinci et al. 2015) . Additionally, we have established Schwann cell lines from normal and ARdeficient C57BL/6 mice. This study aimed at characterizing the biological properties of these cell lines with focus on the physiological and pathological roles of AR in the PNS.
Materials and methods

Animals and cell cultures
Male and female AR-deficient C57BL/6N mice (RRID: MGI:5008184) were obtained from the University of Hong Kong (Ho et al. 2000) and maintained at the Hirosaki University. Normal female C57BL/6 mice were obtained from Japan Clea (Shizuoka, Japan). All mice were fed standard chow and water ad libitum and were housed in a temperature (25°C) and humidity control room with 12 : 12 h light-dark cycle. Five or less mice of each strain were kept in a cage (22 9 22 9 13.8 cm), and all mice received humane care and handling in accordance with the ARRIVE guidelines (Kilkenny et al. 2010) and the Guidelines of the Care and Use of Animals (Tokyo Metropolitan Institute of Medical Science, 2011; institutional approval number 17031 and 17-038). Only three female mice of each strain were used for establishing immortalized Schwann cell lines, and four female normal mice were used for neurite outgrowth and survival assays. No in vivo analyses were performed in this study. No randomization was employed in the allocation of the animals to experimental groups, and the study was not pre-registered.
Primary and long-term Schwann cell cultures were prepared from the dorsal root ganglia (DRG) and adjacent peripheral nerves derived from 8-to 16-week-old female mice as described previously (Sango et al. 2011) with slight modifications; forskolin (F6886; Sigma, St Louis, MO, USA), an inducer of rat Schwann cell proliferation (Sango et al. 2011) , was not added to the medium, because it may inhibit mouse Schwann cell proliferation (Yoshimura et al. 1994) . Mice were anesthetized for euthanasia with 3% isoflurane for 3 min, and DRG with peripheral nerves were dissected. After briefly washing with phosphate-buffered saline (PBS, D8537; Sigma), tissues were incubated in Dulbecco's modified Eagle's medium (DMEM, 11885; Thermo Fisher Scientific Inc., Waltham, MA, USA) containing 0.125% collagenase (CLS-1; Worthington Biochemicals, Freehold, NJ, USA) and 8 U/ mL dispase (354235; Becton Dickinson, Franklin Lakes, NJ, USA) for 1 h at 37°C. After gentle pipetting, the dissociated cells were filtered through a 70-lm Falcon TM cell strainer (352350; Thermo Fisher) and harvested using low-speed centrifugation. After washing in DMEM, the cells were resuspended in DMEM containing 5% fetal bovine serum (FBS, 10270; Thermo Fisher), seeded onto 60 mm plastic dishes, and incubated at 37°C under 5% CO 2 . Feeding medium consisted of serum-free DMEM/Ham's F12 (11330; Thermo Fisher) containing an N2 supplement (17502048; Thermo Fisher), 40 ng/mL neuregulin-b (01-201; EMD Millipore, Billerica, MA, USA), 50 U/mL penicillin, and 50 lg/mL streptomycin (15070063; Thermo Fisher). Neurons, Schwann cells, and fibroblasts in the primary culture were identified through morphology and immunocytochemical staining (data not shown). The culture medium was supplemented twice a week and passaged once every 4-6 weeks, during which the neurons and fibroblasts ceased to grow. After culturing for 4-5 months, spontaneously emerging Schwann cell colonies were isolated and further expanded. For immunocytochemical analysis, cells were seeded onto 10 lg/mL poly-L-lysine (PL, P4707; Sigma)-coated Aclar fluorocarbon coverslips (diameter, 9 mm) (452; Nissin EM Co., Ltd., Tokyo, Japan) at a density of 1-2 9 10 4 cells/coverslip. Cell counter plates (177-112C; Watson Co. Ltd., Tokyo, Japan) were used for calculation and adjustment of the cell density. Spontaneously immortalized Schwann cells were seeded onto dishes and coverslips and maintained in DMEM containing 5% FBS and 20 ng/mL neuregulin-b. A dissociated cell culture of adult mouse DRG neurons was prepared as previously described (Takaku et al. 2013) . Briefly, DRG from the thoracic to lumbar levels were dissected from 8-to 12-week-old female C57BL/6 mice and dissociated using collagenase (CLS-3; Worthington) and trypsin (T8003; Sigma). The DRG were subjected to density gradient centrifugation (5 min, 200 g) with 30% Percoll PLUS TM (17-5445; GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA) to eliminate the myelin sheath. This procedure resulted in a yield of > 5 9 10 4 neurons along with a small number of non-neuronal cells. The cells were then suspended in DMEM/F12 containing 5% FBS and seeded onto PL-coated wells of 8-well chamber slides (177445; Thermo Fisher) or 12-well culture plates (133498; Thermo Fisher) at a density of 0.5-1 9 10 3 cells/cm 2 to study the neurite outgrowth and neuronal cell survival assays described below. D1306; Thermo Fisher) for 5 min at 25°C.
Western blot analysis
Western blot analysis was performed as previously described (Sango et al. 2008b ) with slight modifications. Briefly, protein was extracted from the cultured cells using lysis buffer (10 mM Tris, pH 8.0; 150 mM NaCl; 5 mM EDTA; 1% Triton X-100; 1% NP40; protease inhibitors: aprotinin, benzamidine, leupeptin, pepstatin A, and phenylmethylsulfonyl fluoride). The cell extracts were resolved using sodium dodecyl sulfate polyacrylamide gel electrophoresis in 4-12% NuPAGE Bis-Tris Mini Gels (NP0343BOX; Thermo Fisher) and transferred onto a polyvinylidenefluoride membrane (IPVH00010; EMD Millipore). The membrane was blocked using 5% skimmed milk buffer (10 mM Tris, pH 7.4; 150 mM NaCl; 5% skimmed milk; 1% bovine serum albumin; 0.1% Tween 20) for 2 h at 25°C, and then overnight at 4°C with goat anti-AR polyclonal antibody (1 : 1000; Santa Cruz), goat anti-SDH polyclonal antibody (1 : 1000, RRID:EB06601; Everest Biotech Ltd., Oxfordshire, UK), rabbit anti-ketohexokinase (KHK) polyclonal antibody (1 : 150, RRID:HPA007040; Sigma) or mouse anti-b-actin monoclonal antibody (1 : 3000, RRID:SAB3500350; Sigma). After rinsing with PBS, immunoblotting was performed using peroxidase-conjugated anti-goat (546), anti-rabbit (458), or anti-mouse (330) IgG antibody (1 : 200; MBL Corp., Ltd., Nagoya, Japan) for 2 h. After rinsing, bands were visualized using enhanced chemiluminescence plus a western blotting detection kit (RPN2232; GE Healthcare).
Neurite outgrowth and neuronal cell survival assays Confluent immortalized Schwann cell cultures were incubated for 24 h in serum-free medium (DMEM/F12/N2), and the conditioned medium (CM) was collected, centrifuged, and filter sterilized. CM bioactivities including neurite outgrowth and survival of DRG neurons were assayed as previously described (Sango et al. 2011) . Briefly, adult C57BL/6 mouse DRG neurons were incubated in DMEM/F12 containing 10% FBS on the first day of culturing, and then maintained in DMEM/F12/N2 in the presence or absence of 50 ng/mL recombinant rat glial cell line-derived neurotrophic factor (GDNF, 512-GF; R&D Systems, Inc., Minneapolis, MN, USA) or CM from each Schwann cell line. For the neurite outgrowth assay, neurons cultured for 2 days were fixed with 100% methanol at À20°C for 10 min and incubated overnight at 4°C with the mouse anti-bIII tubulin monoclonal antibody (1 : 2000, T8660; Sigma) and then incubated for 1 h at 37°C with the peroxidase-conjugated anti-mouse IgG antibody (1 : 200; MBL). Immunoreactions were visualized under a light microscope with 0.01% diaminobenzidine tetrahydrochloride (343-00901; Wako Co., Tokyo, Japan) and 0.01% hydrogen peroxide (216763; Sigma) in 50 mM Tris buffer (pH 7.4) at 37°C for 10 min. The number of neurite-bearing cells was expressed as a relative value wherein the total neuron number/ well was assumed to be 100, and the neurite length (in lm) measured from digital images (RRID:SCR_002368; MetaMorph System, Molecular Devices, Inc., Sunnyvale, CA, USA) was expressed as the average value calculated from the measurements of approximately 300 neurites obtained from four different cultures of each experimental group. GDNF was maintained as a positive control because it promotes neurite outgrowth (Takaku et al. 2013) .
For the survival assay, dead neurons were detected using positive trypan blue staining. The number of viable neurons after 7 days in culture was expressed as a relative value wherein the original number at the beginning of incubation was assumed to be 100.
NGF and GDNF in culture supernatants measured by ELISA The amount of nerve growth factor (NGF) and GDNF secreted by immortalized Schwann cells was quantitated using the Emax ImmunoAssay System (G7620 & G7630; Promega) according to the manufacturer's instructions. Briefly, the cells were incubated for 24 h in DMEM/F12/N2, and the culture supernatants were collected and concentrated using Vivaspin ultrafiltration spin columns (28932247; GE Healthcare). In total, 2.5 lg protein from the samples was added to each well of a 96-well plate for the enzyme immunoreactions, and the absorbance was measured at 450 nm using a plate reader (Varioskan Flash, 5250500; Thermo Fisher).
Sorbitol, fructose, and galactitol levels in cells measured by liquid chromatography coupled with tandem mass spectrometry (LC/MS/ MS) analysis Cells were seeded at a density of 2 9 10 5 cells/cm 2 and incubated for 24 h in DMEM containing the following: 1% FBS and 5.6 mM glucose (control); 1% FBS and 30 mM glucose; or 1% FBS, 5.6 mM glucose, and 25 mM galactose. Sorbitol/fructose and galactitol concentrations were then determined using the LC/MS/ MS system, which consists of LC20A or LC-10A (Shimadzu Corp., Kyoto, Japan) and the API4000 tandem mass spectrometer (AB Sciex Pte. Ltd., Framingham, MA, USA) with atmospheric pressure chemical ionization or electrospray ionization. For sorbitol/fructose measurement, the column and autosampler temperatures were 40 and 4°C, respectively. Separation was performed on a CAPCELL PAK NH2 UG80 (5 lm, 4.6 mm I.D. 9 250 mm L.; Shiseido Co., Ltd., Tokyo, Japan) using gradient elution with 0.1% dichloromethane-acetonitrile/water at a flow rate of 1.6 mL/min. The analytical run time was 15 min. For galactitol measurement, the column and autosampler temperatures were 40 and 10°C, respectively. Separation was performed on a CAPCELL PAK NH2 UG80 using 10 mmol/L ammonium acetate/acetonitrile (40/60, v/v) at a flow rate of 1 mL/min. The analytical run time was 5 min. During the assays, investigators were blinded to the experimental groups.
Microarray analysis
Cells were maintained in DMEM containing 1% FBS and 5.6 mM glucose, and total RNA was extracted using RNeasy mini kit (74104; Qiagen, Hilden, Germany). The RNA quality was assessed with a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Cy3-labeled cRNA was prepared with a Low Input Quick Amp Labeling Kit (Agilent Technologies) according to the manufacturer's instructions. The labeled cRNA samples were then hybridized to the Whole Mouse Gene Expression ver.2 4 9 44k Microarray (G4846A; Agilent Technologies), rinsed, and then scanned using a SureScan Microarray Scanner (Agilent Technologies). Microarray data were measured using Feature Extraction software (Agilent Technologies) and analyzed using GeneSpring GX software (Agilent Technologies). Only fold changes of relative expression > 2 were considered to be significant up-regulations and/ or down-regulations.
Real-time RT-PCR
Total RNA was extracted using RNeasy mini kit (Qiagen) and reverse transcribed to cDNA using High-Capacity cDNA Reverse Transcription Kits (4368814; Thermo Fisher). Primers were obtained from Perfect Real-Time primer (Takara Bio Inc., Kusatsu, Japan). Realtime PCR was performed using KAPA SYBR FAST qPCR kit (KK4601; Nippon Genetics, Tokyo, Japan) and a CFX96 Touch RealTime PCR detection system (CFB3120EDU; Bio-Rad Laboratories, Hercules, CA, USA) using the following primer sets: Akr1b3, (forward) 5ʹ-CGGTGTCTCCAACTTCAACC-3ʹ, (reverse) 5ʹ-AGC TTCTCCTGAGTTAGGTACGG-3ʹ (accession no. NM_009658.3); Akr1b7, (forward) 5ʹ-CACTGGCCACAGGGATTTCA-3ʹ, (reverse) 5ʹ-GTTGGAGATGCCCAGAGCTTTC-3ʹ (NM_009731.2); Akr1b8, (forward) 5ʹ-CCAAAGATGACCAAGGCAGA-3ʹ, (reverse) 5ʹ-GA AGTTGGAGACGCCCAGAG-3ʹ (NM_008012.1); Aldh1l2, (for-
The relative mRNA level of each enzyme was normalized to that of b-actin mRNA. All data were expressed as the average values calculated from four experiments.
Viability assay for Schwann cell lines
The viability of Schwann cell lines under exposure to reactive aldehydes, such as methylglyoxal (MG, M0252; Sigma), 3-deoxyglucosone (3-DG, D239150; Toronto Research Chemicals, Toronto, Ontario, Canada), and 4-hydroxynonenal (4HNE, ab141502; Abcam), was determined by RealTime-Glo MT Cell Viability Assay kit (G9711; Promega) according to the manufacturer's instructions. Briefly, cells were seeded at a density of 2 9 10 4 /cm 2 in each well of a 96-well culture plate and incubated for 72 h in DMEM containing 1% FBS and an assay reagent in the presence or absence of MG (0.25 or 0.5 mM), 3-DG (0.25 mM or 0.5 mM), or 4HNE (6.25 or 12.5 lM). The luminescence intensities at 72 h after incubation were measured using a plate reader (ARVO X; Perkin Elmer, Waltham, MA, USA).
Statistical analysis
All data were presented as mean AE standard deviation, and the statistical evaluations of the data were performed using nonparametric one-way ANOVA followed by the 
Results
Characterization of established adult mouse Schwann cell lines IKARS1 and 1970C3
Spontaneously developed colonies were observed after 4-5 months in Schwann cell primary cultures established from the AR-deficient and wild-type C57BL/6 mice, and the established cell lines were designated as immortalized knocked out AR Schwann cells 1 (IKARS1) and 1970C3, respectively. AR gene deletion and deficient AR protein expression in IKARS1 cells were confirmed using the genomic PCR (data not shown) and western blot analysis (Fig. 1a) . Both 1970C3 and IKARS1 cells showed spindle-shaped morphology (Fig. 1b) and intense immunoreactivity to S100, p75 NTR , and vimentin (Fig. 1c) , which was similar to the longterm cultured Schwann cells and IMS32 cell line (Watabe et al. 1995; Sango et al. 2006) . AR immunoreactivity was detected in 1970C3 cells, but not in IKARS1 cells (Fig. 1c) .
Conditioned media obtained from IKARS1 and 1970C3 cells promoted DRG neuronal survival and neurite outgrowth After 2 days in culture, CM from both Schwann cell lines significantly increased the neurite-bearing cell percentages (Fig. 2a) and the average neurite length (lm) (Fig. 2b ) to levels comparable with those of GDNF. After 7 days in culture, CM from both cell lines significantly increased the percentage of viable neurons, whereas GDNF tended to slightly increase the survival ratio (Fig. 2c) . The phasecontrast micrographs of DRG neurons at 7 days in culture (Fig. 2d) indicate that CM from both cell lines can promote not only neuronal cell survival, but also proliferation of Schwann cells remaining in the neuron-enriched solution after density gradient centrifugation with 30% Percoll.
Subsequent ELISA assay with the culture supernatants indicated that NGF and GDNF were secreted by the 1970C3 and IKARS1 cells (Fig. 2e ). Because these molecules have been shown to promote neurite outgrowth from adult rodent DRG neurons (Wiklund et al. 2002; Takaku et al. 2013) , it is likely that they play a role in the neurotrophic activities of CM. No significant differences were observed in CM bioactivity or the amounts of NGF or GDNF detected in the supernatants between the two cell lines (Fig. 2e) .
Intracellular polyol levels under normal and glucose/ galactose-loading conditions
In addition to the conversion of glucose to sorbitol, AR also catalyzes the conversion of galactose to galactitol. To confirm a deficient AR activity in IKARS1 cells, we measured the intracellular contents of sorbitol and fructose under normal (5.6 mM) and high glucose (30 mM) conditions, and the content of galactitol in the presence or absence of 25 mM galactose, respectively. Under normal glucose condition, the contents of sorbitol and fructose in 1970C3 cells appeared slightly increased compared with those in IKARS1 cells, but no significant differences were detected in the average values between them. There was a trend of increase in the levels of sorbitol and fructose in 1970C3 cells under exposure to high glucose conditions, but the changes were not statistically significant as compared with the values under normal glucose conditions. Similarly, a high glucose load had no influence on the contents of these polyols in IKARS1 cells; however, the values under high glucose conditions were significantly lower than those in 1970C3 cells (Fig. 3a) . Moreover, using other statistical methods, such as Mann-Whitney U test and Student's t-test, we observed significant differences (p < 0.05) in the polyol contents between 1970C3 and IKARS1 under high glucose conditions. These findings suggest deficient AR function in the polyol metabolism in IKARS1 cells. Unlike sorbitol, galactitol is not a SDH substrate and accumulates in cells under galactosemic conditions (Berry 1995; Sato et al. 2003) . After a 24-h exposure to 25 mM galactose, the galactitol content significantly increased in 1970C3 cells, but not in IKARS1 cells. Moreover, galactitol level up-regulation in 1970C3 cells was significantly suppressed by co-treatment with an AR inhibitor, ranirestat (Fig. 3b) .
mRNA/protein expression down-regulation of polyol pathway-related enzymes SDH and KHK in IKARS1 cells AR is a member of AKR superfamily; mouse AR (aka AKR1B3) is encoded by the Akr1b3 gene (Yabe-Nishimura 1998; Sango et al. 2006) . Microarray analysis was conducted to detect the down-regulation or up-regulation of genes affected by Akr1b3 deletion in Schwann cells. The expression of Sord encoding SDH and Khk encoding ketohexokinase (KHK; EC 2.7.1.3, aka fructokinase) was markedly down-regulated (> sevenfold) in IKARS1 cells relative to 1970C3 cells (Table 1) . These findings were confirmed using subsequent real-time RT-PCR analysis, which revealed a markedly lower expression of Sord and Khk in IKARS1 cells compared with those in 1970C3 cells under normal (5.6 mM) and high glucose (30 mM) conditions (Fig. 4a) . Furthermore, western blot analysis indicated a deficient protein expression of AR, SDH, and KHK in IKARS1 cells under normal and high glucose conditions (Fig. 4b) .
Up-regulation of aldo-keto reductase and aldehyde dehydrogenase mRNA expression in IKARS1 cells
In contrast to the down-regulation of Sord and Khk, the expression of the following seven genes was significantly up-regulated (> twofold) in IKARS1 cells compared with that in 1970C3 cells using microarray analysis: Akr1b8 and Akr1c14 encoding AKR1B8 and AKR1C14, respectively, and Aldh1b1, Aldh1l2, Aldh3b1, Aldh5a1, and Aldh7a1 encoding the aldehyde dehydrogenase (ALDH) 1B1, ALDH1L2, ALDH3B1, ALDH5A1, and ALDH7A1, 
Aldh7a1
Aldehyde dehydrogenase 7 family, member A1
Aldehyde dehydrogenase activity A_51_P470414, A_55_P2101231
2.1
Only fold changes of relative expression > 2 are considered to be significant. There are 2 up-regulated genes and 7 down-regulated genes in IKARS1 compared with 1970C3. respectively (Table 1) . For microarray data validation, realtime RT-PCR was performed. We failed to detect the expression of Akr1c14 and Aldh1b1 because of the difficulty of primer design, but confirmed the up-regulation of Akr1b8, Aldh1l2, Aldh5a1, and Aldh7a1 in IKARS1 cells relative to 1970C3 cells under the normal glucose (5.6 mM) condition (Fig. 5) . It is slightly surprising that Aldh3b1 expression was significantly down-regulated in IKARS1 cells relative to 1970C3 cells, and the reason for such discrepant findings between microarray and RT-PCR analyses remains unclear.
Up-regulation of mRNA expression of AR-related enzymes AKR1B7 and AKR1B8 in IKARS1 cells under exposure to reactive aldehydes AR is suggested to play a role in reactive biogenic aldehyde detoxification, such as 3-DG, MG, and 4HNE (Takahashi et al. 1995; Rittner et al. 1999; Chang et al. 2002) . However, no significant differences were detected in the viability between IKARS1 and 1970C3 cells under exposure to these aldehydes (Fig. 6a) . These findings indicate that the detoxifying function of AR may be taken over by other AKRs and/ or ALDHs (Vasiliou et al. 2000; Lyon et al. 2013) . The mouse genome contains four transcriptionally active Akr1b genes, including Akr1b3, Akr1b7, Akr1b8, and the recently identified Akr1b16 (Salabei et al. 2011; Pastel et al. 2012) . The encoded proteins AKR1B7 (aka major vas deferens protein) and AKR1B8 (aka fibroblast growth factor induced-1) have been considered as mouse AR-related proteins because of the high degree of sequence similarities to AR (AKR1B3) (Yabe-Nishimura 1998; Petrash 2004 ). Thus, we conducted a real-time RT-PCR analysis to compare Akr1b7 and Akr1b8 expressions between two Schwann cell lines in the presence or absence of these aldehydes. Although the microarray analysis revealed that Akr1b7 was not among the up-regulated genes (Table 1) , Akr1b7 expression in IKARS1 cells was significantly higher than that in 1970C3 cells under control conditions (Fig. 5 ). Exposure to 3-DG, MG, or 4HNE significantly up-regulated Akr1b7 and Akr1b8 expressions in IKARS1 cells, but not in 1970C3 cells (Fig. 6b) . In contrast, the same aldehyde insults failed to up-regulate Aldh1l2, Aldh5a1 and Aldh7a1 expressions in both cell lines ( Figure S1 ).
Discussion
Previous experiments have helped establish spontaneously immortalized Schwann cell lines from normal mice and rats, such as IMS32 (Watabe et al. 1995) , 1970C3 (present study), and IFRS1 (Sango et al. 2011) , as well as from mice with targeted gene mutations that are recognized as murine models of lysosomal storage diseases (NiemannPick type C, Krabbe, Sandhoff, and Fabry diseases), Charcot-Marie-Tooth disease type 1B, and neurofibromatosis (Sango and Yamauchi 2014) . Cell lines from mutant mice have been shown to retain genomic and biochemical abnormalities, sufficiently representing pathological features of respective diseases. In contrast to such disease models, AR-deficient mice exhibited no apparent phenotypes in the nervous system and were protected from diabetes-induced reduction of nerve conduction velocity and sural nerve fiber loss (Ho et al. 2006) . Therefore, IKARS1 cells established from AR-deficient mice appear to be useful for complete investigation of the pathological roles of AR under diabetic conditions. In addition, novel and unexpected findings regarding the physiological functions of AR in the PNS may be obtained by conducting experiments with IKARS1 and 1970C3 cells that have originated from the C57BL/6 mouse strain. The findings illustrated in Figs 1 and 2 indicate that both cell lines retained one of the fundamental properties of Schwann cells, that is, the production and secretion of various neurotrophic factors and cytokines that promote neuronal survival and axonal regeneration after injury (Jessen and Mirsky 2016) . Furthermore, ELISA assays confirmed the synthesis and extracellular release of NGF and GDNF by both cell lines (Fig. 2e) . Because these well-characterized neurotrophic factors are secreted by Schwann cells (Ma et al. 2015) and promote neurite outgrowth from adult rodent DRG neurons (Gavazzi et al. 1999; Takaku et al. 2013) , the neurotrophic activities of CM can be, at least partly, attributable to these molecules. In contrast, no significant effects of NGF or GDNF on DRG neuron viability were observed both in the previous (Lindsay 1988; Sango et al. 2008b) as well as present studies. Few other molecules that have been shown to enhance DRG neuron survival (e.g., ciliary neurotrophic factor, leukemia inhibitory factor, oncostatin M, and cardiotrophin-1) (Sango et al. 2008b) may be involved in the neuroprotective activities of CM. Moreover, CM appeared to induce Schwann cell proliferation that had remained in the neuron-enriched primary culture (Fig. 2d) . It seems plausible that some factors secreted from these cell lines act on Schwann cells in a paracrine manner. However, the search for active factors contained in CM is beyond the scope of this study and will need to be discussed elsewhere. Because no significant differences were detected between 1970C3 and IKARS1 cells in the bioactivities of CM on DRG neurons or the amount of NGF/GDNF released into culture medium, AR deficiency seems unlikely to affect the ability of Schwann cells to produce neurotrophic and neuroprotective molecules.
AR has been considered an essential enzyme for the conversion of glucose to sorbitol and galactose to galactitol (Yabe-Nishimura 1998; Petrash 2004) . The findings that a load of 30 mM glucose had no influence on the content of sorbitol or fructose in IKARS1 cells (Fig. 3a) are consistent with marked down-regulation of mRNA/protein expression of SDH and KHK in IKARS1 cells compared with that in 1970C3 cells (Table 1 , Fig. 4 ). It seems reasonable that AR gene deletion leads to gene inactivation for SDH and KHK, which are downstream of AR in the polyol pathway (Hassel et al., 2015) . However, it is surprising that detectable amounts of sorbitol and fructose were observed in the ARdeficient cells under both culture conditions. These findings agree with the existence of sorbitol and fructose in the sciatic nerves of AR-deficient mice (Ho et al. 2006) and imply that AR-related enzymes may take over the catalytic function of AR, such as the conversion of glucose to sorbitol in IKARS1 cells as well as in AR-deficient mice. In addition, galactitol content detection in IKARS1 cells under exposure to 25 mM galactose (Fig. 3b) indicates the conversion of galactose to galactitol in the absence of AR. An in-depth discussion regarding such functional redundancies between AR and other enzymes will be presented later.
Although the high glucose load led to a trend of increase in sorbitol/fructose contents in 1970C3 cells, no significant differences were detected in the average values between the normal and high glucose conditions (Fig. 3a) . These findings are similar to those of primary cultured adult rat Schwann cells (Suzuki et al. 1999) and Schwann cell lines JS1 (Mizisin et al. 1996) and IFRS1 (Sango and Yamauchi 2014) , but in sharp contrast to the marked accumulation of sorbitol and fructose in IMS32 cells exposed to high glucose conditions (Sango et al. 2006 (Sango et al. , 2008a HY, NN, ST and KS, unpublished data) . It remains to be investigated why the same hyperglycemic insults clearly escalate the flux through the polyol pathway in IMS32 cells but only slightly in 1970C3. The exposure to 30 mM glucose for 24-48 h significantly up-regulated AR mRNA/protein expression in IMS32 cells (Sango et al. 2008a) but not in 1970C3 cells (Fig. 4) . Therefore, such a short-term exposure to high glucose conditions may be insufficient to augment glucose flux through the polyol pathway in 1970C3 cells. It also is possible that the flux through other collateral pathways (e.g., hexosamine pathway, protein kinase C pathway, and AGE pathway), rather than the polyol pathway, may be predominantly activated in 1970C3 cells because of glycolytic pathway saturation (Brownlee 2001) . In contrast to the high glucose load, exposure of 1970C3 cells to 25 mM galactose for 24 h resulted in marked up-regulation of galactitol content, which was significantly suppressed by co-treatment with an AR inhibitor ranirestat (Fig. 3b) . These findings suggest that enhanced AR activity in response to galactose load is involved in the increase of galactitol levels in 1970C3 cells. Similar findings were obtained with other Schwann cell lines, such as IMS32 and IFRS1 cells (KS, NN, HY, ST, HK and TM, unpublished data) . Given that galactose is recognized as a better substrate for AR than glucose (YabeNishimura 1998; Petrash 2004) , it seems reasonable to state that galactose load is a more rapid and potent trigger of AR activation than high glucose load in Schwann cells. Additionally, galactitol is not metabolized by SDH and appears to accumulate in cells at a rate faster than that of sorbitol and fructose.
Previous studies have focused mostly on the pathological role of AR and polyol pathway in the development and progression of diabetic neuropathy and other complications (Gabbay 1975; Brownlee 2001) ; similarly, the benefits of AR inhibition in neuropathy have been extensively studied in experimental diabetic animals and patients with diabetes (Yagihashi et al. 2011; Hotta et al. 2012) . In contrast, reactive aldehyde detoxification appears to be an important physiological function of AR under normoglycemic conditions (Rittner et al. 1999; Pladzyk et al. 2006) , but the protective role of AR against these aldehydes has not been completely discussed. Although AR is suggested to be an efficient catalyst for the reduction of 3-DG, MG, and 4HNE (Takahashi et al. 1995; Rittner et al. 1999; Chang et al. 2002) , the viability assay revealed that AR gene deletion failed to enhance aldehyde toxicity in Schwann cells (Fig. 6a) . In addition, we have previously observed that treatment with the AR inhibitor fidarestat did not exacerbate MG-induced Schwann cell death (Sango et al. 2008a) . These findings result from the complex metabolic disposal system of toxic aldehydes; several enzymes other than AR, including other AKRs, ALDHs, and glutathione-dependent glyoxalase systems, can also participate in the detoxification of these substances (Vasiliou et al. 2000; Kuhla et al. 2006; Lyon et al. 2013; Morgenstern et al. 2017) . Interestingly, all the up-regulated genes in IKARS1 cells encode the enzymes affiliated with AKR or ALDH superfamily ( Table 1 ). Considering that these AKRs and ALDHs are involved in the reduction and oxidation of various aldehydes (Singh et al. 2015) , the microarray data indicate functional redundancies between these enzymes and AR. The subsequent real-time RT-PCR analysis confirmed the up-regulation of mRNA expression of AKR1B8, ALDH1L12, AlDH5A1, and ALDH7A1 in IKARS1 cells relative to 1970C3 cells under basal conditions (Fig. 5) . However, we observed discrepant findings between microarray and real-time RT-PCR analyses, that is, mRNA expression of AKR1B7 and ALDH3B1, as described in the Results section. Although the reasons for such differences remain unclear, it is known that microarray and quantitative PCR data often disagree (Morey et al. 2006) . In the present study, we focused on the four enzymes up-regulated in IKARS1 cells by both microarray and real-time RT-PCR analyses, and AKR1B7 that has long been considered as an AR-related enzyme, as well as AKR1B8 (Salabei et al. 2011; Pastel et al. 2012) . The real-time RT-PCR analysis showed the up-regulation of mRNA expression of AKR1B7 and AKR1B8 in IKARS1 cells under exposure to 3-DG, MG, or 4HNE (Fig. 6b) . It seems reasonable to assume that AR deficiency can lead these enzymes to be greatly involved in aldehyde reduction. Currently, we have not obtained antibodies against AKR1B7 or AKR1B8 that are applicable to immunohistochemistry or western blotting; however, future studies with these antibodies and/or siRNAinduced mRNA knockdown of these enzymes will help in investigating the redundant disposal systems of toxic aldehydes.
In conclusion, 1970C3 and IKARS1 can be useful tools for the study of polyol metabolism and functional roles of AR. Our ongoing studies with these cell lines focus on the association between polyol pathway hyperactivity and other pathogenic mechanisms leading to diabetic neuropathy (e.g., glycation, oxidative stress, and Rho/Rho kinase hyperactivity). 
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